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Abstract
Purpose Thermal rheology (TR) fluid, which comprises polyethylene (PE) particles, their dispersant, and solvent, is a 
material that increases in viscosity to various degrees depending on the type and ratio of these constituents when its tem-
perature rises. The viscosity of type 1 (TRF-1) increases more than that of type 2 (TRF-2) near rabbit body temperature. 
This preliminary animal study aimed to determine the basic characteristics and embolic effect of TR fluid by comparing 
TRF-1 and TRF-2.
Materials and methods Twenty-four Japanese white rabbits underwent unilateral renal artery embolization using TRF-1 
or TRF-2 and follow-up angiography at 7 or 28 days (4 subgroups, n = 6 each). Subsequently, the rabbits were euthanized, 
and the embolized kidneys were removed for pathological examination. The primary and final embolization rates were 
defined as the ratio of renal artery area not visible immediately after embolization and follow-up angiography, respectively, 
to visualized renal artery area before embolization. The final embolization rate and maximum vessel diameter filled with PE 
particles were compared between materials. Moreover, the embolic effect was determined to be persistent when a two-sided 
95% confidence interval (CI) for the difference in means between the embolization rates was < 5%.
Results The final embolization rate was significantly higher for the TRF-1 than for the TRF-2 at both 7 (mean 80.7% [SD 
18.7] vs. 28.4% [19.9], p = 0.001) and 28 days (94.0% [3.5] vs. 37.8% [15.5], p < 0.001). The maximum occluded vessel 
diameter was significantly larger for TRF-1 than for TRF-2 (870 µm [417] vs. 270 µm [163], p < 0.001). The embolic effect 
of TRF-1 was persistent until 28 days (difference between rates − 3.3 [95% CI − 10.0–3.4]).
Conclusion The embolic effect of TRF-1 was more persistent than that of TRF-2, and the persistency depended on the type 
and ratio of TR fluid constituents.
Keywords Thermal rheology fluid · Intravascular embolic material · Transarterial embolization · Animal study
Introduction
The side-chain crystalline block copolymer (SCCBC), a 
dispersant that reduces the viscosity of a concentrated poly-
ethylene (PE) particle suspension, was developed by Yao 
et al. [1–6]. The SCCBC consists of a long alkane side-
chain unit that can be adsorbed on the crystalline surface of 
PE particles via van der Waals forces and a functional unit 
(FU) with solvent affinity. Therefore, by the action of the 
SCCBC, a PE particle suspension exists as a low-viscosity 
fluid; however, as the temperature of the suspension rises 
above the so-called “transition temperature,” the crystalline 
part of SCCBC melts, van der Waals forces disappear, and 
the suspension dramatically increases in viscosity and turns 
into almost solid state [3, 6]. This temperature-dependent 
change in viscosity is reversible [1–3, 6]. This phenomenon 
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was named thermal rheology (TR); accordingly, the PE 
particle suspension containing SCCBC is called TR fluid 
(Fig. 1) [2, 6]. The transition temperature and the degree of 
increase in viscosity can be adjusted by changing the type 
and ratio of TR fluid constituents: the side-chain crystalline 
unit (SCCU) of SCCBC, the FU of SCCBC, PE particles, 
and their solvent [2, 5, 6]. TR fluid is prepared without using 
a special experimental apparatus and consists of low-cost 
materials [7]; in addition, TR fluid is stable to external 
stimuli, and its effect is maintained over a long period [6]. 
Hence, we can repeatedly change the type and ratio of TR 
fluid constituents to obtain a mixture with the desired func-
tion, and the TR fluid can be stored until use. As a result 
of such trial-and-error, TR fluids that may be suitable as a 
new embolic material for transcatheter arterial embolization 
were developed with the following characteristics: transition 
temperature adjusted to body temperature, and a radiopaque 
material containing a contrast medium as the solvent. This 
TR fluid is liquid outside the body but could behave like a 
solid when injected into blood vessels.
Various embolic materials, including gelatin sponges 
(GS), trisacryl gelatin microspheres, n-butyl-2-cyanoacr-
ylate (NBCA), and metallic coils, are in widespread 
clinical use [7]. Although each is associated with distinct 
strengths, each also has limitations. Thus, the availability 
of a new embolic material increases the likelihood of bet-
ter embolic therapy, and it is meaningful to investigate 
whether a TR fluid with a unique TR effect could be used 
as an embolic material. Moreover, although Hirai et al. 
reported that TR fluid could be used as an embolic agent, 
its detailed characteristics need further elucidation [8].
In this study, we used a rabbit model to determine the 
basic characteristics and embolic effect of TR fluid by 
comparing two types of TR fluids with different viscosity-
temperature relationships: types 1 (TRF-1) and 2 (TRF-2).
Fig. 1  Schematic of the mecha-
nism of the thermal rheology 
effect and the appearance of 
thermal rheology fluid. At a 
temperature lower than the 
transition temperature, the 
side-chain crystalline block 
copolymer (SCCBC) is attracted 
to polyethylene (PE) surface 
by van der Waals forces and is 
epitaxially arrayed to the PE 
surface because of structural 
similarity of the side-chain crys-
talline unit (SCCU) of SCCBC 
to PE. The strong adsorption 
of SCCBC on the PE surface is 
caused by cocrystal formation. 
As a result, the functional units 
(FUs) of SCCBC cover the PE 
surface and form a new layer, 
which precludes aggregation 
between PEs; hence, the ther-
mal rheology (TR) fluid exists 
in this state as a low-viscosity 
fluid. On the other hand, at a 
temperature higher than the 
transition temperature, the crys-
talline part of SCCBC melts, 
van der Waals forces disappear, 
and SCCBC is desorbed from 
PE surface. As a result, PE 
regains its original properties 
and aggregates; the TR fluid 
increases in viscosity and turns 
into almost solid state. Viscos-
ity changes dramatically and 
reversibly near the melting point 
of SCCBC




All experiments were approved by the Animal Experimenta-
tion Committee of our institute and conducted in accordance 
with the Animal Care Guidelines.
A total of 24 Japanese white rabbits (body weight: 
2.5–3.0 kg), which were obtained from an animal breed-
ing company (KITAYAMA LABES CO., LTD, Nagano, 
Japan), were used in this study. The mean rectal temperature 
of the rabbits was 39.1 °C (SD 0.4). They were housed in 
our animal room under constant environmental conditions 
(temperature: 22 ± 1 °C, humidity: 60 ± 5%, 12 h light/dark 
cycle), and received 150 g rabbit feed (CR-3 M, Clea Japan 
Inc., Tokyo) daily with clean drinking water ad libitum.
SCCBC
SCCBC and TR fluid were prepared and stored under clean 
conditions. The procedures for preparing these materials are 
shown in Fig. 2.
Two types of SCCBCs were prepared in this study: 
SCCBC-1 and SCCBC-2. For SCCBC-1 and SCCBC-2, 
stearyl acrylate (Tokyo Chemical Industry, Tokyo, Japan) 
and hexadecyl acrylate (Tokyo Chemical Industry) were 
selected as SCCUs, respectively. Diethylene glycol ethyl 
ether acrylate (Sigma-Aldrich Japan, Inc., Tokyo, Japan) 
and acrylic acid (Tokyo Chemical Industry) were selected 
as the FUs of SCCBC-1 and -2, respectively. Each SCCBC 
was synthesized by nitroxide-mediated living radical polym-
erization, as previously reported [5]. Briefly, the SCCU, 
2-methyl-2-[N-tert-butyl-N-(1-diethoxyphosphoryl-2,2-
dimethyl-propyl)aminoxy]propionic acid (BlocBuilder MA, 
Arkema Inc., Colombes, France) as an initiator, and butyl 
acetate (Wako Pure Chemical Industries, Osaka, Japan) as a 
solvent were added to a nitrogen-purged flask. The mixture 
was then stirred at 110 °C. After 1 day, a solution of the 
FU in butyl acetate was added to the mixture and polymer-
ized. One day later, the solution was exposed to air and rap-
idly cooled to quench polymerization. Finally, the reactants 
were dissolved in butyl acetate, reprecipitated with methanol 
(Wako Pure Chemical Industries) for purification, and dried 
under vacuum. Consequently, the white solids SCCBC-1 and 
-2 were obtained.
TR fluid
Two different types of TR fluids, TRF-1 and TRF-2, were 
prepared in this study as these would allow us to assess 
the viscosity-temperature relationship with changes in the 
type and ratio of TR fluid constituents. Basically, TRF-1 
was made by adding contrast media to the original TR fluid, 
developed as a dispersant for PE particle suspension. In 
Fig. 2  Preparations of a side-chain crystalline block copolymer 
and thermal rheology fluid. Side-chain crystalline block copolymer 
(SCCBC) is prepared as follows: first, the side-chain crystalline unit 
(SCCU), BlocBuilder MA as an initiator, and butyl acetate as a sol-
vent are added to a nitrogen-purged flask. The mixture is then stirred 
at 110 °C for one day, and a solution of the functional unit (FU) in 
butyl acetate is added to the mixture and polymerized for one more 
day. Next, the solution is exposed to air and rapidly cooled to quench 
polymerization. Finally, the reactants are dissolved in butyl acetate, 
reprecipitated with methanol and dried under vacuum. Thermal rhe-
ology (TR) fluid is prepared as follows: first, SCCBC is dissolved in 
ethanol by stirring at 60 °C, and PE particles are added to this solu-
tion and stirred. Subsequently, the ethanol was removed by vacuum 
drying for one day. Next, a solvent is added, mixed, homogenized by 
performing two cycles of heating to 60 °C and cooling to room tem-
perature, and then stored as a TR fluid
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addition, the constituent ratio was adjusted to increase the 
viscosity at near rabbit body temperature. TRF-2 was made 
from the original TR fluid and contained a large amount of 
contrast media. It did not contain ethanol as solvent; there-
fore, the FU was changed to maintain solvent affinity. The 
SCCU type and the TRF-2 constituent ratio were adjusted 
to increase the viscosity at near rabbit body temperature.
The preparations of TR fluids were as follows: first, 
SCCBC-1 or -2 was dissolved in ethanol (Wako Pure 
Chemical Industries) by stirring at 60 °C, and PE particles 
(average diameter: 7.4 µm, Ceridust 3620, Clariant Japan, 
Tokyo, Japan) were added to this solution and stirred. Sub-
sequently, the ethanol was removed by vacuum drying 
for 1 day. The obtained substances were composed of 2% 
SCCBC and 98% PE particles. Next, the solvent was added, 
mixed, homogenized by performing two cycles of heating 
to 60 °C and cooling to room temperature, and then stored 
as a TR fluid. TRF-1 contained 25% ethanol, 40% contrast 
medium (350 mg I/mL, Iomeron, Eisai, Tokyo, Japan), and 
35% SCCBC-1-bound PE particles; TRF-2 contained 75% 
contrast medium and 25% SCCBC-2 bound PE particles. 
SCCBC-1 comprised 0.7% of the total volume of TRF-1, 
and SCCBC-2 comprised 0.5% of the total volume of TRF-2.
TRF-1 and TRF-2 were designed so that their viscosity 
would increase at near rabbit body temperature and be vis-
ible under fluoroscopy (Fig. 3). The temperature dependence 
of the TR fluid viscosity is shown in Fig. 4. The viscosities 
of the TR fluid at 25, 35, 45, 55, and 65 °C were measured 
using a cone-plate rheometer (Rheosol-G2000W, UBM Co., 
Ltd., Kyoto, Japan).
Embolization
The laboratory room temperature was maintained at 25 °C 
using an air conditioner. Each rabbit was anesthetized with 
an intramuscular injection of medetomidine hydrochloride 
(0.1 mg/kg body weight; Domitor, Zonoac, Fukushima, 
Japan) and ketamine hydrochloride (20 mg/kg body weight; 
Ketalar, Daiichi Sankyo, Tokyo, Japan). Once anesthetized, 
the rabbits were placed supine, and their upper and lower 
limbs were tied to the operating table.
The right femoral artery was exposed, and a 4-F intro-
ducer sheath (Super sheath, length: 7 cm, Medikit, Tokyo, 
Japan) was inserted into the aorta via a cut-down approach. 
A 4-F cobra-shaped catheter (Terumo Clinical Supply, 
Gifu, Japan) was placed into a single renal artery through 
Fig. 3  Properties of the thermal 
rheology fluid. The thermal 
rheology (TR) fluid (type 1, 
TRF-1) behaves as a low-vis-
cosity fluid at room temperature 
of 25 °C (a) and is extruded 
from the microcatheter as a 
rod-shaped solid body at 40 °C, 
which is close to rabbit body 
temperature (b). Type 2 TR 
fluid (TRF-2) appears to be less 
cohesive than TRF-1 at 40 °C 
(c). Both TRF-1 and TRF-2 (left 
side and right side, respectively) 
in the Petri dish (above) and 
1-mL syringe (below) show 
visibility in the fluoroscopic 
image: the latter is better (d)
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the introducer sheath, and digital subtraction angiography 
(DSA) was performed by manual injection of 4 mL of 50% 
diluted iodine contrast medium (370 mg I/mL, Iopamidol 
370, Bayer Yakuhin, Osaka, Japan) using an X-ray fluor-
oscopy system (Plessart 50 DREX-WIN20P, Canon Medi-
cal Systems, Tochigi, Japan). We selected either the right 
or left renal artery. The radiation parameters used for DSA 
were as follows: 70 kV output voltage, 50 mA current, and 
40 ms pulse width. A 2.2-Fr distal, 2.9-Fr proximal micro-
catheter (Sniper 2, 110 cm; Terumo Clinical Supply) was 
then advanced to the tip of the 4-F catheter, and liquid TR 
fluid collected in a 2.5 mL syringe (Terumo Syringe, Ter-
umo, Tokyo, Japan) was continuously delivered through the 
microcatheter until either embolization of the renal artery 
or filling of the segmental arteries and additional periph-
eral arteries was achieved. TRF-1 and TRF-2 were used for 
12 rabbits each. After embolization, DSA was performed 
again in the same manner, and the catheter and sheath were 
removed. Subsequently, the femoral artery was ligated.
Follow‑up angiography
The embolized renal artery was catheterized via the left fem-
oral artery, and follow-up DSA was performed. Each group 
of 12 rabbits were randomly divided into subgroups a and 
b (n = 6 each). Subgroups 1–a and 2–a underwent follow-
up DSA 7 days after embolization and subgroups 1–b and 
2–b 28 days after embolization. The follow-up period was 
decided based on reports describing GS particles as a tempo-
rary embolic material. It was reported that GS particles com-
pletely disappear from the embolized vessels in pathological 
images within 2–3 weeks, resulting in recanalization [9–11].
Histopathology
After follow-up angiography, the rabbits were euthanized 
using pentobarbital (Nembutal, Dainippon Sumitomo 
Pharma Co., Ltd., Tokyo, Japan), and their embolized kid-
neys were removed. The specimens were fixed in 10% for-
malin, embedded in paraffin, cut into 3.5 µm sections, and 
stained with hematoxylin–eosin for microscopic examina-
tion. Pathological images were captured using an Olympus 
IX83 microscope (Olympus).
Assessment
Angiographic and pathological images were analyzed 
using ImageJ software, version 1.53a (National Institutes 
of Health, Bethesda, MD, USA). The areas of the renal 
arterial vessels visualized during the arterial phase of pre-
embolization DSA, post-embolization DSA, and follow-up 
DSA were measured. Specifically, for each angiography, 
we selected for measurement an image in which branch-
shaped renal arterial vessels, but not renal parenchyma, 
were stained. The area of interest was selected in each 
image, followed by masking the extra black areas such as 
the renal capsule artery (Fig. 5). Next, a threshold was 
set to distinguish the area of renal arterial vessels filled 
with contrast media from the background, and the area was 
calculated automatically. The primary and final emboliza-
tion rates indicated the embolization rate immediately after 
embolization and that at the time of follow-up DSA (days 
7 or 28), respectively, and were defined and calculated as 
follows:
Fig. 4  Relationship between the 
temperature and viscosity of 
thermal rheology fluid. The vis-
cosity of the thermal rheology 
(TR) fluid changes dramatically 
when approaching rabbit body 
temperature. Note that type 1 
TR fluid (TRF-1) has a greater 
increase in viscosity near body 
temperature than does type 2 
TR fluid (TRF-2)
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The primary and final embolization rates were com-
pared between subgroups 1–a and 2–a (DSA on day 7) and 
between subgroups 1–b and 2–b (DSA on day 28). Further-
more, to determine whether the embolic effect was persistent 
in each subgroup, a two-sided 95% confidence intervals (CI) 
for the mean differences between the primary embolization 
rate and final embolization rate, representing the time course 
Primary embolization rate (%) =
(
1 −
the area of renal arterial vessels visualized on post - embolization DSA
the area of renal arterial vessels visualized on pre - embolization DSA
)
× 100;
Final embolization rate (%) =
(
1 −
the area of renal arterial vessels visualized on follow - up DSA
the area of renal arterial vessels visualized on pre - embolization DSA
)
× 100.
of the embolization rate (%), were calculated; when the 95% 
CI was < 5%, we determined that the embolic effect was per-
sistent, and when the 95% CI was > 15%, the embolic effect 
was determined to be not persistent.
Pathology was assessed by observing the size and color 
of the embolized kidneys, distribution of PE particles in the 
renal arterial vessels, and renal parenchymal changes such 
as inflammation and necrosis. The maximum vessel diameter 
filled with PE particles was measured microscopically for 
each rabbit, and the range of embolization was compared 
between the TRF-1 and TRF-2 groups.
Statistical analysis
Continuous data were presented as means with standard 
deviations (SDs). The Welch t test was used for all com-
parisons. Statistical significance was set at p < 0.05. Statisti-
cal analyses were performed using IBM SPSS Statistics for 
Macintosh, Version 25 (IBM Corp., Armonk, NY, USA).
Results
Angiographic analysis
The TR fluid was visible on fluoroscopy and passed through 
the microcatheter without occlusion, although some resist-
ance, which seems to have been caused by an increase in 
viscosity of the TR fluid, was present during the injection. 
In addition, when injecting TR fluid, there was no reflux 
into the aorta or migration toward a non-target artery. In 
all rabbits, the embolization procedure was performed suc-
cessfully, and post-embolization DSA showed that the renal 
arterial vessels and renal parenchyma were barely visible 
(Fig. 6a–d). The baseline characteristics are presented in 
Table 1.
In the TRF-1 group, the delineation of the renal arterial 
vessels on follow-up DSA was similar to that on post-embo-
lization DSA (Fig. 6e), while in the TRF-2 group, recanali-
zation was observed on follow-up DSA (Fig. 6f). In terms 
of the final embolization rate, the embolic effect of TRF-1 
was significantly more persistent than that of TRF-2 at both 
Fig. 5  The measurement method of the areas of renal arterial vessels. 
We selected for measurement an image in which stained tree-shaped 
renal arterial vessels but not the renal parenchyma was visible (a). 
First, the area of interest (the area bordered by a blue rectangle) was 
selected (a). The extra black areas, such as the renal capsule artery, 
were masked (b). A threshold was then set to distinguish the area of 
renal arterial vessels filled with contrast media (colored blue) from 
the background (c), and the area was calculated automatically
Japanese Journal of Radiology 
1 3
7 (mean 80.7% [SD 18.7] vs. 28.4% [19.9], p = 0.001) and 
28 days (94.0% [3.5] vs. 37.8% [15.5], p < 0.001) days after 
embolization (Table 1).
In subgroup 1–b, the embolic effect was persistent (dif-
ference between rates − 3.3 [95% CI − 10.0–3.4]; Table 1). 
However, the embolic effect of TRF-2 was not persistent 
(difference between rates 62.6 [95% CI 40.9–84.2] and 50.4 
[30.0–70.8]; Table 1).
Pathological analysis
In both groups, the embolized kidneys were atrophied and 
hard, with irregular edges, and had turned grayish-white 
in color. Microscopic analysis revealed PE particles occu-
pying the arterial vessels, inflammatory cell infiltration, 
fibrosis, and necrosis around the vessels (Fig. 7a, b). The 
area of necrosis was greater in the TRF-1 group than in 
Fig. 6  Angiographic findings. 
In both type 1 and 2 thermal 
rheology fluids (TRF-1 and 
TRF-2, respectively) groups, 
pre-embolization angiography 
allowed visualization of all 
branches of the renal artery 
and renal parenchyma (a and 
b, respectively), whereas these 
were not visible in post-embo-
lization angiography (c and d, 
respectively). In TRF-1 group, 
although the renal capsule 
artery was visualized, the 
delineation of renal arterial ves-
sels on angiography at 28 days 
was similar to that on post-
embolization angiography, and 
no recanalization of the renal 
artery occurred (e). In TRF-2 
group, recanalization of the 
embolized vessels was observed 
on angiography at 28 days (f)
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the TRF-2 group. More specifically, in the TRF-1 group, 
most tubular epithelial cells were necrotic; in the TRF-2 
group, most tubular epithelial cells were necrotic at the 
cortical margin, rarely necrotic on the hilar side, and the 
degree of necrosis was intermediate in the middle part. 
PE particles were present as clusters almost without the 
intervention of blood cells or blood clots and were dis-
tributed from the peripheral small arterial vessels toward 
Table 1  Embolization rates and 
their time course in the four 
subgroups
The time-course of embolization rate (%) is the mean difference between the primary embolization rate and 
the final embolization rate
Primary embolization rate (%) = (1 − the area of renal arterial vessels visualized on post-embolization 
DSA/ the area of renal arterial vessels visualized on pre-embolization DSA) × 100
Final embolization rate (%) = (1 − the area of renal arterial vessels visualized on follow-up DSA/the area 
of renal arterial vessels visualized on pre-embolization DSA) × 100
TRF-1 and TRF-2 = type 1 and 2 thermal rheology fluids, respectively. SD standard deviation. LL and UL 
represent the lower limit and upper limit of the confidence interval (CI), respectively
a The embolic effect was determined to be persistent, because the 95% CI was < 5%












Time course of emboli-
zation rate
n Mean SD p value Mean SD p value % 95% CI [LL, UL]
1-a (7 days, TRF-1) 6 90.4 6.1 0.905 80.7 18.7 0.001** 9.7 [− 9.1, 28.6]
2-a (7 days, TRF-2) 6 91.0 8.2 28.4 19.9 62.6 [40.9, 84.2]b
1-b (28 days, TRF-1) 6 90.6 4.0 0.582 94.0 3.5  < 0.001***  − 3.3 [− 10.0, 3.4]a
2-b (28 days, TRF-2) 6 88.2 8.5 37.8 15.5 50.4 [30.0, 70.8]b
Fig. 7  Microscopic findings. 
The cluster of polyethylene (PE) 
particles (arrows) containing 
almost no blood cells or blood 
clots filled the renal arterial 
vessels in both type 1 thermal 
rheology fluid (TRF-1) group 
(a) and type 2 thermal rheology 
fluid (TRF-2) group (b). Inflam-
matory cell infiltration occurred 
in the renal sinus area around 
the vessels (left side of the dot-
ted lines; a). Loss of the tubular 
epithelial nucleus, suggesting 
tissue necrosis, was observed in 
the renal parenchyma (arrow-
head; b). Neither PE particles 
nor their phagocytosis was 
seen outside the renal arterial 
vessels. The largest vessels 
filled with PE particles were 
the segmental artery, which was 
surrounded by renal sinus fat, 
and the cortical radiate artery 
inside the renal parenchyma, 
in TRF-1 group (a) and TRF-2 
group (b), respectively. PE par-
ticles (arrow) were continuously 
distributed from the periphery 
toward the central side (c)
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the central side in both groups (Fig. 7a–c). Neither PE 
particles nor evidence of phagocytosis was seen outside 
the renal arterial vessels. The maximum vessel diameter 
occluded by PE particles was significantly larger in the 
TRF-1 group than in the TRF-2 group (mean 870 µm [SD 
417] vs. 270 µm [163], p < 0.001). In the TRF-1 group, 
the measured vessels were renal arteries or segmental 
arteries, surrounded by renal sinus fat (Fig. 7a); in the 
TRF-2 group, most of the measured vessels were inter-
lobar arteries or more peripheral arteries inside the renal 
parenchyma (Fig. 7b).
Discussion
TRF-1 and TRF-2 showed different embolic effect. This 
result is consistent with previous reports, which dem-
onstrated that the relationship between temperature and 
viscosity of TR fluid differed depending on the type and 
ratio of its constituents [2, 5, 6]. In other words, modi-
fied TR fluids have new embolic effect. It is suggested 
that a TR fluid with desired embolic effect customized 
for each situation can be obtained. TR fluid seems to be 
safely usable on living organisms under the usual precau-
tions: the pathological changes after embolization with 
TR fluid were similar to those of renal infarction caused 
by other etiologies [12–14]; the PE particles themselves 
remained in the vessels, and no specific adverse reactions 
were observed.
Although the embolic effect of TRF-2 was not persis-
tent, it may act as a temporary embolic material; however, 
such usage should be carefully considered. This is because 
the PE particles in TRF-2 may continue to circulate in 
the blood vessels for a long period after recanalization of 
the renal arteries, although the effect of such circulating 
PE particles on living organisms is currently unknown. 
Consequently, TRF-2 might gradually embolize micro-
vessels in organs throughout the body. It is possible that 
the viscosity of TRF-2 at rabbit body temperature was 
not sufficient as an embolic material and that the shear-
ing effect of blood flow gradually washed it away. The 
PE particles were considered to have low bio-absorption, 
because no phagocytosis was observed in the pathological 
images; additionally, non-aggregated PE particles with a 
size of 7.4 µm are likely to pass through the micro-vessels. 
In the case of TRF-1, the degree of embolization remained 
unchanged on follow-up angiography after 28 days. More-
over, the renal arterial vessels, including the proximal 
arteries such as the renal artery and the segmental artery, 
were pathologically embolized by aggregated PE. Based 
on these findings, TRF-1 could be used as a permanent 
embolic material.
Our findings indicated that TR fluid has a potential 
as a new embolic material with different characteristics 
from existing liquid embolic materials. When using abso-
lute ethanol or other radiolucent materials, the real-time 
state of embolization cannot be observed during proce-
dure. This is associated with the risk of non-target vessel 
embolization. In contrast, TR fluid has good visibility, can 
be monitored under fluoroscopy, and was safely injected. 
Catheter occlusion, catheter adhesion to vessel walls, and 
the resulting vessel or catheter rupture have been reported 
as complications of NBCA [15–17], which is classified 
as the same liquid embolic material as TR fluid. NBCA 
must be injected quickly because these complications are 
due to its premature polymerization. Furthermore, NBCA 
carries a high risk of non-target embolization [17–19]. 
Training and considerable experience in the effective use 
of NBCA are required to avoid these complications [15, 
20]. In contrast, TR fluid is easy to administer, because it 
can be delivered without haste and does not block the cath-
eter. In fact, TR fluid did not occlude the microcatheter. 
Nakai et al. reported that NBCA-lipiodol-ethanol (NLE) 
has multiple advantages for embolization over NBCA, 
such as fewer adhesive properties to the catheter and less 
damage features to the vascular wall [21–24]. TR fluid and 
NLE appear to have similar advantages for embolization, 
although they have different embolic mechanisms.
For treating acute arterial bleeding in a coagulopathic 
state, NBCA, which does not depend on biogenic coagu-
lants, is more useful than other embolic materials, includ-
ing GS particles and metallic coils [15, 25–28]. Several 
studies have reported that NBCA was a good embolic 
material with a high hemostasis rate even in patients with 
coagulopathy [29–33]. The pathological findings of the 
current study indicated that the action of TR fluid did not 
depend on biogenic coagulants, that is, PE particles filled 
the blood vessels without the aid of thrombi. Therefore, 
like NBCA, TR fluid should be suitable for patients with 
coagulopathy. Further examination of TR fluid is war-
ranted to determine its clinical indications, including 
traumatic bleeding and massive gastrointestinal bleeding.
Our study has several limitations. The first is its small 
sample size, which may explain why the persistency of the 
embolic effect could not be determined in subgroup 1-a. 
Furthermore, inter-individual variation as well as the pro-
gression of renal blood vessels atrophy could cause higher 
embolization rate observed on day 28 than on day 7. How-
ever, the use of the minimum necessary animals is recom-
mended for ethical reasons. The second is the short follow-
up period. Further investigations should examine longer 
term embolic effect. The inflexibility of TR fluid is also a 
limitation. The embolic effect of NBCA can be changed 
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immediately before use by adjusting the mixing ratio with 
lipiodol, while TR fluid must be already adjusted accord-
ing to the subject’s body temperature. Finally, our results 
merely demonstrated that TR fluid embolized the rabbit 
renal artery: TR fluid was not compared to existing liquid 
embolic materials such as NBCA and absolute ethanol. 
Thus, we plan to conduct a comparative study between TR 
fluid and other embolic materials.
In conclusion, the embolic effect of TRF-1 was 
more persistent than that of TRF-2, and the persistency 
depended on the type and ratio of TR fluid constituents.
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